British Columbia Centre on Substance Use, Vancouver, Canada.
Department of Medicine, University of British Columbia, Vancouver, Canada.
Subst Abus. 2021;42(4):775-779. doi: 10.1080/08897077.2020.1864569. Epub 2021 Feb 22.
With the emergence of unregulated fentanyl, people who use unregulated opioids are increasingly relying on appearance in an effort to ascertain the presence of fentanyl and level of drug potency. However, the utility of visual inspection to identify drug composition in the fentanyl era has not been assessed. We assessed client expectation, appearance, and composition of street drug samples being presented for drug checking. Results of a visual screening test were compared to fentanyl immunoassay strip testing. We calculated sensitivity, specificity and likelihood ratios (LR) to assess the accuracy of the common assumption that samples with a "pebbles" appearance contain fentanyl. In total, of the 2502 unregulated opioid samples tested, 1820 (73.5%) appeared as "pebbles", of which 1729 (95.0%) tested positive for fentanyl for a sensitivity of 75.9% (95% Confidence Interval [CI]: 74.2-77.6) and specificity of 59.4% (95%CI: 57.5-61.3). Although, the odds of samples containing fentanyl was 4.60 (95%CI: 3.47-6.11) times higher among pebbles samples compared to non-pebble samples, the positive LR for pebbles to contain fentanyl was only 1.87 (CI: 1.59-2.19). The negative LR was more useful at 0.41 (95% CI: 0.36-0.46). A positive screening test for pebbles is not strongly enough associated to be used as a proxy for detecting fentanyl. While the absence of the appearance of pebbles does somewhat reduce the likelihood of fentanyl being present in a given sample, the high prevalence of fentanyl and fentanyl analogues in the drug supply and the risks of consumption are such that public health providers should routinely advise people who use unregulated opioids against solely relying on visual characteristics of drugs as a harm reduction strategy.
随着不受监管的芬太尼的出现,使用不受监管的阿片类药物的人越来越依赖外观来确定芬太尼的存在和药物效力。然而,在芬太尼时代,视觉检查识别药物成分的效用尚未得到评估。我们评估了客户对呈现用于药物检测的街头毒品样本的外观、成分的预期。视觉筛查测试的结果与芬太尼免疫测定条测试进行了比较。我们计算了敏感性、特异性和似然比(LR),以评估这样一个常见假设的准确性,即外观呈“卵石”状的样本含有芬太尼。在总共测试的 2502 个不受监管的阿片类药物样本中,1820 个(73.5%)呈“卵石”状,其中 1729 个(95.0%)对芬太尼检测呈阳性,敏感性为 75.9%(95%置信区间[CI]:74.2-77.6),特异性为 59.4%(95%CI:57.5-61.3)。尽管卵石状样本中含有芬太尼的可能性是无卵石状样本的 4.60 倍(95%CI:3.47-6.11),但卵石状样本中含有芬太尼的阳性 LR 仅为 1.87(CI:1.59-2.19)。阴性 LR 在 0.41(95% CI:0.36-0.46)时更有用。卵石状样本的阳性筛查测试与检测芬太尼的关联性不够强,不能作为替代方法。虽然卵石状外观的不存在在一定程度上降低了给定样本中存在芬太尼的可能性,但在药物供应中,芬太尼和芬太尼类似物的高流行率以及消费风险是如此之大,以至于公共卫生提供者应常规建议使用不受监管的阿片类药物的人不要仅仅依靠药物的外观特征作为减少伤害的策略。